Cowen & Co. Downgrades Lyft to Market Perform
Cowen & Co. analyst John Blackledge downgrades Lyft (NASDAQ:LYFT) from Outperform to Market Perform.
Cowen & Co. Downgrades Wayfair to Market Perform, Lowers Price Target to $38
Cowen & Co. analyst John Blackledge downgrades Wayfair (NYSE:W) from Outperform to Market Perform and lowers the price target from $80 to $38.
Cowen & Co. Downgrades AdTheorent Holding to Market Perform, Lowers Price Target to $2.5
Cowen & Co. analyst John Blackledge downgrades AdTheorent Holding (NASDAQ:ADTH) from Outperform to Market Perform and lowers the price target from $4 to $2.5.
Cowen & Co. Downgrades Imago BioSciences to Market Perform, Announces $36 Price Target
Cowen & Co. analyst Marc Frahm downgrades Imago BioSciences (NASDAQ:IMGO) from Outperform to Market Perform and announces $36 price target.
Jefferies Downgrades Imago BioSciences to Hold, Raises Price Target to $36
Jefferies analyst Maury Raycroft downgrades Imago BioSciences (NASDAQ:IMGO) from Buy to Hold and raises the price target from $35 to $36.
Cowen & Co. Downgrades Sea to Market Perform, Lowers Price Target to $60
Cowen & Co. analyst John Blackledge downgrades Sea (NYSE:SE) from Outperform to Market Perform and lowers the price target from $72 to $60.
MongoDB Analysts See Upside Over Long-Term, Thanks To Fast-Growing Database Market
Morgan Stanley analyst Sanjit Singh downgraded MongoDB, Inc (NASDAQ:MDB) from Overweight to Equal-Weight and cut the price target from $368 to $215.…
Wedbush Downgrades Imago BioSciences to Neutral, Raises Price Target to $36
Wedbush analyst Robert Driscoll downgrades Imago BioSciences (NASDAQ:IMGO) from Outperform to Neutral and raises the price target from $25 to $36.
Northland Capital Markets Downgrades Power Integrations to Market Perform
Northland Capital Markets analyst Gus Richard downgrades Power Integrations (NASDAQ:POWI) from Outperform to Market Perform.
Barclays Downgrades Williams-Sonoma to Equal-Weight, Lowers Price Target to $114
Barclays analyst Adrienne Yih downgrades Williams-Sonoma (NYSE:WSM) from Overweight to Equal-Weight and lowers the price target from $192 to $114.